Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gene Security Network, a molecular diagnostics company, has closed its $6 million series B financing.
Subscribe to our email newsletter
Participating in the financing were existing investors Claremont Creek Ventures and Sequoia Capital as well as new investor Alafi Capital.
Matthew Rabinowitz, president and CEO of Gene Security Network, said: “The financing from this top syndicate at a high valuation is a testament to the rapid progress we’ve made to deliver accurate testing from a single cell.
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life of their patients.”